
Sign up to save your podcasts
Or


Christopher Cahoon, PharmD elucidates the literature pertaining to injectable cabotegravir and rilpivirine as HIV therapy options.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.6
4545 ratings
Christopher Cahoon, PharmD elucidates the literature pertaining to injectable cabotegravir and rilpivirine as HIV therapy options.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

78,300 Listeners

261 Listeners

289 Listeners

3,338 Listeners

56,394 Listeners

43 Listeners

401 Listeners

12 Listeners

18 Listeners

15 Listeners

9 Listeners

14,017 Listeners

14 Listeners

5 Listeners